Investment
Features
FeesSafety
Academy
More
Pluang+

Tokenized US Treasury bills on Stellar rise $96.2M in a week, pushing real-world assets to $3.47B.

Protocol Fundamentals
06 Oct 2026
Crypto Briefing
View Source
Bullish
Tokenized US Treasury bills on Stellar rise $96.2M in a week, pushing real-world assets to $3.47B.

The market capitalization of tokenized US Treasury bills on the Stellar network increased by $96.2 million in one week, contributing to a growing base of real-world assets on the platform now valued at approximately $3.47 billion. This growth is driven by major issuers like J.P. Morgan and Franklin Templeton, with the latter's BENJI product playing a key role since its 2021 launch. While Ethereum leads overall Treasury token volumes and outpaced Stellar's growth in the same week, Stellar's steady inflows highlight its expanding role in tokenizing real-world assets. However, weekly figures can fluctuate as funds move between networks, so trends depend on issuer strategies going forward.

Stellar's tokenized US Treasury bills recently added $96.2 million in market capitalization within one week, reflecting growing interest in tokenized real-world assets. For readers following the cryptocurrency market, here is Pluang's market snapshot as of Oct 07, 2026 00:03 WIB: of 50 major cryptocurrencies priced on Pluang, 24 rose and 25 fell today. Notable movers include EOS at Rp12.649 (+8.13%), FIL at Rp20.810 (+6.64%) with a Pluang order activity of 56% Sell / 44% Buy, and AVAX at Rp204.576 (+5.17%) with a Pluang order activity of 35% Sell / 65% Buy.

More News

Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...

Company Fundamentals
Neutral
43 minutes ago
Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...

Analyst Insights
Bullish
1 hour ago
Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup has raised its price target for AstraZeneca to £186.00 from £178.00, maintaining a Buy rating following successful Phase 3 clinical trials. The increase reflects higher peak sales forecasts for drugs tozorakimab and SERENA-6, offsetting the...

Analyst Insights
Bullish
1 hour ago
Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

An analyst from BMO Capital set a $67 price target for Devon Energy, suggesting a 40% upside from its current share price of around $48. The oil and gas producer has consistently beaten earnings estimates recently, showing strong financial health. Ho...

Analyst Insights
Bullish
2 hours ago
$10,000 in Marvell stock 10 years ago is now worth about $206,000, needing 35% annual growth to repeat.

$10,000 in Marvell stock 10 years ago is now worth about $206,000, needing 35% annual growth to repeat.

An investment of $10,000 in Marvell stock a decade ago has grown to approximately $206,000 today. Achieving the same growth again would require an annual earnings increase of 35%. This highlights Marvell's strong past performance and the challenge of...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App